Larimar Therapeutics LRMR
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Larimar Therapeutics (LRMR) Business Model and Operations Summary
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.
Key Insights
Larimar Therapeutics (LRMR) Core Market Data and Business Metrics
Latest Closing Price
$2.25Market Cap
$117.17 MillionAverage Trade Volume
1,103,405 SharesTotal Outstanding Shares
64.03 Million SharesCEO
Dr. Carole S. Ben-Maimon M.D.Total Employees
65IPO Date
May 29, 2020SIC Description
Pharmaceutical PreparationsPrimary Exchange
NASDAQHeadquarters
Three Bala Plaza East. Suite 506, Bala Cynwyd, PA, 19004
Earnings Reports
Expected vs. Actual Quarterly Earnings-Per-Share & Revenue
Short Volume
Daily short volume activity identifies short-term trading pressure and potential price volatility
Revenue Breakdown
Distribution of revenue across unique business segments & geographies
Historical Stock Splits
| Execution Date | Split Amount |
|---|